Abcentra
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Abcentra is a clinical-stage biopharmaceutical company developing first-in-class therapeutic antibodies to treat cardiovascular inflammation by blocking oxidized LDL.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abcentra Comparables
Compare Abcentra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novartis | 78% | |
| DalCor Pharmaceuticals | 71% | |
| Novo Nordisk | 71% |
Abcentra Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 31% QoQ, from 13 to 17 employees.
- Jul 29, 2026
Grew 23% QoQ, from 13 to 16 employees.
Abcentra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Abcentra's valuation, stock price, and market status.
Is Abcentra a public or private company?
Abcentra is a private company.
What is the current stock price of Abcentra?
Abcentra is a private company, so its shares have no public market price. Caplight tracks Abcentra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abcentra worth (valuation)?
Valuation information for Abcentra is not publicly available.
Can I buy Abcentra stock?
Abcentra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abcentra's last funding round?
Funding round information for Abcentra is not publicly available.
Who are the main investors in Abcentra?
Investor information for Abcentra is not publicly disclosed.
Will Abcentra IPO soon?
No public IPO plans have been announced for Abcentra.
How can I track Abcentra secondary market activity?
Caplight tracks bids, offers, and trades in Abcentra's shares on secondary markets.